PF-04620110 Uses, Dosage, Side Effects and more
PF-04620110 is under investigation in clinical trial NCT01146327 (A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects).
| Trade Name | PF-04620110 |
| Generic | PF-04620110 |
| Type | |
| Formula | C21H24N4O4 |
| Weight | Average: 396.447 Monoisotopic: 396.179755269 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
